Use of bisphophonates for inhibiting bone resorption...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/675 (2006.01) A61K 31/66 (2006.01)

Patent

CA 2188030

Disclosed is a therapy for treating and for preventing periprosthetic bone loss by the administration of a bisphosphonate bone resorption inhibitor, e.g., alendronate, in patients who have an orthopedic implant device.

Thérapie de traitement et de prévention des pertes osseuses périprothétiques par administration d'un biphosphonate inhibiteur de résorption osseuse tel que l'alendronate à un patient porteur d'un implant orthopédique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of bisphophonates for inhibiting bone resorption... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of bisphophonates for inhibiting bone resorption..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of bisphophonates for inhibiting bone resorption... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2065545

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.